Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-054833

EVP, Research & CSO sold 5,560 shares at $43.03 ($239,236)

  • EVP, Research & CSO acquired 5,560 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-10-13 Option exercise +5,560 $1.53 $8,507 29,260 D
Virgin Herbert EVP, Research & CSO 2020-10-13 Sale −5,560 $43.03 $239,236 23,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-10-13 Option exercise · Stock Option (Right to Buy) −5,560 454,315 D
Open-market sales · 5,560 sh · avg $43.03 · $239,236
Loading xslF345X03/doc4.xml…